Linical : Consolidated Financial Results for the Nine Months Ended December 31, 2022 (Japanese GAAP)(311kb)

[REFERENCE TRANSLATION]

Please note that this translation is to be used solely as reference and the financial statements in this material are unaudited. In case of any discrepancy between this translation and the Japanese original, the latter shall prevail.

This translation is subject to change without notice. Linical Co., Ltd. shall accept no responsibility or liability for damage or loss caused by any error, inaccuracy, misunderstanding, or changes with regard to this translation.

	Consolidated Financial Results
	for the Nine Months Ended December 31, 2022
	(Japanese GAAP)
	February 14, 2023
Company name	：Linical Co., Ltd.
Stock Listing	：Tokyo Stock Exchange
Code No.	：2183
URL	：https://www.linical.co.jp/
Representative	：Kazuhiro Hatano, President & Chief Executive Officer
Contact	：Akihiro Takahashi, Executive Vice President, Chief Financial Officer

Scheduled date of filing of quarterly report

: February 14, 2023

Scheduled date of start of dividend payment

: －

Preparation of supplementary materials for the quarterly

: No

financial statements

Holding of presentation for the quarterly financial results

: No

（All amounts are rounded down to the nearest million yen）

1．Consolidated Financial Results for the Nine Months Ended December 31, 2022

（April 1, 2022 to December 31, 2022）

(1)Consolidated Financial Results (cumulative)

（% figures show year-on-year change）

Net sales

Operating income

Ordinary income

Profit attributable to

owners of parent

Nine Months Ended

(¥ million)

change(％)

(¥ million)

change(％)

(¥ million)

change(％)

(¥ million)

change(％)

December 31, 2022

9,246

7.3

740

△11.5

768

△9.2

577

10.0

December 31, 2021

8,613

14.4

836

302.9

846

683.8

524

234.1

（Note） Comprehensive income

Nine Months Ended December 31, 2022:

¥ 778 million (15.5%)

Nine Months Ended December 31, 2021:

¥673 million (278.8%)

Net income per share

Diluted net income

per share

Nine Months Ended

(¥)

(¥)

December 31, 2022

25.57

－

December 31, 2021

23.24

－

(2)Consolidated Financial Position

Total assets

Net assets

Shareholders'

Net asset per

equity ratio

share

(¥ million)

(¥ million)

(％)

(¥)

As of December 31, 2022

16,847

7,005

41.6

310.15

As of March 31, 2022

15,716

6,543

41.6

289.69

（Reference）Shareholder's equity:

As of December 31, 2022:

¥7,005 million

As of March 31, 2022:

¥6,543 million

2．Dividends

Annual dividends per share (¥)

1st Quarter End

2nd Quarter End

3rd Quarter End

Fiscal

Total

Year End

Year Ended March 31, 2022

－

0.00

－

14.00

14.00

Year Ending March 31, 2023

－

0.00

－

Year Ending March 31,

14.00

14.00

2023(Forecast)

(Note）Change in the dividend forecast from the most recent announcement: No

3．Forecast of Consolidated Financial Result for the Year Ending March 31, 2023

(April 1, 2022 to March 31, 2023)

（% figures show year-on-year change）

Profit attributable

Net income

Net sales

Operating income

Ordinary income

to owners of

per share

parent

(¥ million)

％

(¥ million)

％

(¥ million)

％

(¥ million)

％

(¥)

Full year

12,440

7.7

1,224

12.7

1,204

1.7

871

10.2

38.56

(Note）Change in forecasts of consolidated financial results from the most recent announcement: No

※ Notes
(1)Changes	in significant	subsidiaries during the period(changes in specified	：No
subsidiaries that caused changes in scope of consolidation)
New:	-	(Company Name)	-
Exclusion:	-	(Company Name)	-
(2)Adoption	of	accounting	methods specific to the	preparation of quarterly	：No
consolidated	financial statements

(3)Changes in accounting policies, accounting estimates and restatements

1)Changes in accounting policies resulting from the revision of the accounting standards and other regulations

2)Changes in accounting policies other than 1) 3)Changes in accounting estimates 4)Restatements

(4)Number of issued shares (Common share)

(a)Number of issued shares at the end of the period (including treasury shares)

：Yes

：No

：No

：No

As of	December 31, 2022
As of	March 31, 2022

(b) Number of treasury shares at the end of the period

As of	December 31, 2022
As of	March 31, 2022

1. Average number of shares during the period Nine Months Ended December 31, 2022 Nine Months Ended December 31, 2021

：24,740,000 shares

：24,740,000 shares

：2,153,564 shares

：2,153,564 shares

：22,586,436 shares

：22,586,436 shares

• This release is outside the scope of the external auditor's quarterly review procedure.
• Explanation on appropriate use of forecast and other special items

This material contains business forecast and other forward-looking statements which are based on available information and certain assumptions that are considered reasonable at the time of preparation. Various factors may cause actual results, etc. to be materially different from those expressed in these forward-looking statements.

Consolidated Balance Sheets

		(Thousands of yen)
	As of March 31, 2022	As of December 31, 2022
Assets
Current assets
Cash and deposits	5,985,618	6,753,942
Accounts receivable - trade and contrac	2,917,990	3,051,295
Prepaid expenses	197,784	254,522
Advances paid	987,891	1,136,687
Other	266,645	330,268
Allowance for doubtful accounts	△34,842	△12,253
Total current assets	10,321,087	11,514,462
Non-current assets
Property, plant and equipment	664,111	630,569
Intangible assets
Goodwill	3,406,633	3,401,590
Other	159,249	134,186
Total intangible assets	3,565,883	3,535,777
Investments and other assets
Investment securities	347,652	334,208
Long-term prepaid expenses	5,461	1,470
Guarantee deposits	366,280	372,956
Deferred tax assets	445,992	458,410
Total investments and other assets	1,165,387	1,167,045
Total non-current assets	5,395,381	5,333,392
Total assets	15,716,469	16,847,854

Consolidated Balance Sheets

		(Thousands of yen)
	As of March 31, 2022	As of December 31, 2022
Liabilities
Current liabilities
Short-term borrowings	600,000	600,000
Current portion of long-term borrowings	539,976	539,976
Accounts payable - other	533,842	689,794
Accrued expenses	402,485	347,835
Income taxes payable	193,650	146,549
Accrued consumption taxes	38,747	96,763
Advances received	2,147,272	2,443,595
Deposits received	688,038	1,426,954
Provision for bonuses	171,809	98,073
Other	162,279	157,204
Total current liabilities	5,478,102	6,546,746
Non-current liabilities
Long-term borrowings	2,533,566	2,128,584
Lease liabilities	430,959	412,020
Retirement benefit liability	689,644	721,531
Other	41,028	33,770
Total non-current liabilities	3,695,198	3,295,906
Total liabilities	9,173,300	9,842,652
Net assets
Shareholders' equity
Share capital	214,043	214,043
Retained earnings	6,604,985	6,866,294
Treasury shares	△657,461	△657,461
Total shareholders' equity	6,161,567	6,422,876
Accumulated other comprehensive income
Valuation difference on available-for-	42,339	40,240
sale securities
Foreign currency translation adjustment	322,124	525,933
Remeasurements of defined benefit plans	17,138	16,151
Total accumulated other comprehensive	381,601	582,325
income
Total net assets	6,543,169	7,005,202
Total liabilities and net assets	15,716,469	16,847,854

Consolidated statements of income (cumulative)

			(Thousands of yen)
		Nine months ended	Nine months ended
		December 31, 2021	December 31, 2022
Net sales	8,613,651	9,246,539
Cost of sales	5,934,911	6,256,857
Gross profit	2,678,739	2,989,682
Selling, general and administrative expenses	1,842,072	2,249,346
Operating profit	836,666	740,336
Non-operating income
Interest income	423	441
Foreign exchange gains	24,311	57,453
Total non-operating income	24,734	57,895
Non-operating expenses
Interest expenses	10,979	9,962
Loss on valuation of investment securities	2,781	19,864
Other	1,561	-
Total non-operating expenses	15,322	29,826
Ordinary profit	846,079	768,404
Extraordinary income
Insurance claim income	-	66,202
Gain on liquidation of subsidiaries	-	35,358
Settlement recieved	160,486	-
Total extraordinary income	160,486	101,560
Extraordinary losses
Arbitration related expenses	136,594	-
Information security expenses	99,053	-
Business restructuring expenses	-	26,619
Loss on cancellation of leases	-	20,478
Total extraordinary losses	235,648	47,098
Profit before income taxes	770,917	822,867
Income taxes - current	230,399	239,607
Income taxes - deferred	15,623	5,739
Total income taxes	246,023	245,347
Profit	524,893	577,519
Profit attributable to owners of parent	524,893	577,519